growth and the mice survival rate increased compared with the free
drug [111]. Docetaxel and tamoxifen are potent drugs against breast
cancer. There is an antagonistic problem when both drugs are used in
combination because they have different metabolisms. Docetaxel and
tamoxifen loaded TPGS-PLA showed a significant reduction of the
drug antagonism in the MCF7 cell line [112].